Biogen's Tecfidera Approved as Expected; Launch in 'Days'
Just days after winning a thumbs-up from the European Committee for Medicinal Products for Human Use, Biogen Idec Inc.'s much-lauded Tecfidera was approved by the FDA, and analysts have said the drug has a good shot against the two oral multiple sclerosis therapies already on the market.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter